Skip to main content
Caplight Logo









QCDx

QCDx

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://www.qcd-x.com/

Last Round

Debt

May 1, 2025

Total Funding Raised

$8.9M

Company Overview

QCDx is a biotechnology company that develops and provides liquid biopsy technologies and instruments for the detection and proteomic profiling of circulating tumor cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsycirculating tumor cellsCTCcancer diagnosticssingle-cell analysis3D optical tomographyfluorescence microscopycancer research toolsbiotech hardwareAI image analysisprecision oncologydrug discoveryclinical laboratoryCLIA labcancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QCDx Comparables

Compare QCDx with similar companies based on industry and business-model similarity.

QCDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vortex Biosciences
82%
Rarecells
81%
Menarini Group
74%

QCDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 1, 2025
SeedMay 1, 2025
Convertible DebtDec 20, 2019
Convertible DebtFeb 6, 2018
Convertible DebtDec 15, 2017

Key People

Founding team and executive leadership

Fyl Tafas

Founder CEO

Founding Team

Triantafyllos Tafas

Founder CEO

Founding Team

QCDx Investors

Notable investors and investment history

QCDx investors
InvestorRounds
Connecticut InnovationsConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    $7M debt round completed.

QCDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

QCDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QCDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range26
Year Founded2017
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?